Cargando…

Expression of CD133, E-cadherin and WWOX in colorectal cancer and related analysis

OBJECTIVE: To detect the expression of CD133, E-cadherin and WWOX in colorectal cancer, analyze the correlations and pathological significance of the biomarkers. METHODS: Two hundred and ten patients with colorectal cancer treated surgically between January 2007 and December 2015 were analyzed retro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Wenwen, Dou, Jinxia, Zhang, Lin, Qiao, Likui, Shen, Na, Gao, Wenyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432716/ https://www.ncbi.nlm.nih.gov/pubmed/28523049 http://dx.doi.org/10.12669/pjms.332.11687

Ejemplares similares

CD133 expression correlates with membrane beta-catenin and e-cadherin loss from human hair follicle placodes during morphogenesis
por: Gay, Denise, et al.
Publicado: (2014)

Prognostic significance of E-Cadherin and CD44 expression in tumor tissue of colorectal carcinoma
por: Knezevic, T, et al.
Publicado: (2015)

Neonatal neuronal WWOX gene therapy rescues Wwox null phenotypes
por: Repudi, Srinivasarao, et al.
Publicado: (2021)

Association Between the Immunohistochemistry Expression of E-cadherin, Beta-Catenin, and CD44 in Colorectal Adenocarcinoma
por: Tunuguntla, Amrutha, et al.
Publicado: (2023)

Utility of immunohistochemical expression of E-cadherin in colorectal carcinoma
por: Rajkumar, Sharmilla Devi, et al.
Publicado: (2021)

WWOX expression in colorectal cancer—a real-time quantitative RT-PCR study
por: Żelazowski, Maciej Jakub, et al.
Publicado: (2011)

Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
por: Suman, Sweta, et al.
Publicado: (2023)

Decreased WWOX expression promotes angiogenesis in osteosarcoma
por: Wen, Jia, et al.
Publicado: (2017)

CD133 expression is an independent prognostic marker for low survival in colorectal cancer
por: Horst, D, et al.
Publicado: (2008)

Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
por: Wang, Ke, et al.
Publicado: (2012)

Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma
por: Park, Youn Young, et al.
Publicado: (2019)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

WWOX-Related Neurodevelopmental Disorders: Models and Future Perspectives
por: Steinberg, Daniel J., et al.
Publicado: (2021)

Expression of WW domain–containing oxidoreductase WWOX in pterygium
por: Huang, Yi-Hsun, et al.
Publicado: (2015)

Correlation between osteosarcoma and the expression of WWOX and p53
por: Liu, Pingtao, et al.
Publicado: (2017)

Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
por: Zhang, Yanfei, et al.
Publicado: (2013)

Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
por: Li, Wanlu, et al.
Publicado: (2017)

WWOX Possesses N-Terminal Cell Surface-Exposed Epitopes WWOX(7-21) and WWOX(7-11) for Signaling Cancer Growth Suppression and Prevention In Vivo
por: Wang, Wan-Jen, et al.
Publicado: (2019)

CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Chen, Shicai, et al.
Publicado: (2013)

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
por: Oliver, Jaime Antonio, et al.
Publicado: (2014)

Augmented CD133 expression in distal margin correlates with poor prognosis in colorectal cancer
por: Pradhan, Tapas, et al.
Publicado: (2019)

ARE STEM CELL MARKER EXPRESSION AND CD133 ANALYSIS RELEVANT TO DIFFERENTIATE COLORECTAL CANCER?
por: CZECZKO, Leticia Elizabeth Augustin, et al.
Publicado: (2021)

ARE STEM CELL MARKER EXPRESSION AND CD133 ANALYSIS RELEVANT TO DIFFERENTIATE COLORECTAL CANCER?
por: CZECZKO, Leticia Elizabeth Augustin, et al.
Publicado: (2021)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

E-cadherin and Snail Immunoexpression in Colorectal Adenocarcinomas
por: AL KHATIB, AM, et al.
Publicado: (2019)

Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
por: Hong, Injae, et al.
Publicado: (2015)

CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009)

WWOX Phosphorylation, Signaling, and Role in Neurodegeneration
por: Liu, Chan-Chuan, et al.
Publicado: (2018)

WWOX loss activates aerobic glycolysis
por: Abu-Remaileh, Muhannad, et al.
Publicado: (2014)

The WWOX gene in brain development and pathology
por: Kośla, K, et al.
Publicado: (2020)

WWOX and Its Binding Proteins in Neurodegeneration
por: Hsu, Che-Yu, et al.
Publicado: (2021)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma
por: Gao, Minna, et al.
Publicado: (2016)

Prognostic significance of E-cadherin and N-cadherin expression in Gliomas
por: Noh, Myung-Giun, et al.
Publicado: (2017)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Cancer stem cells CD133 and CD24 in colorectal cancers in Northern Iran
por: Nosrati, Anahita, et al.
Publicado: (2016)

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
por: WANG, CHUNXIA, et al.
Publicado: (2012)

LINC01137/miR-186-5p/WWOX: a novel axis identified from WWOX-related RNA interactome in bladder cancer
por: Kołat, Damian, et al.
Publicado: (2023)

Alternating expression levels of WWOX tumor suppressor and cancer-related genes in patients with bladder cancer
por: PŁUCIENNIK, ELŻBIETA, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1iav8v83oi9a0l113m2bvsdltr